Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01. [electronic resource]
Producer: 20060713Description: 1436-45 p. digitalISSN:- 0007-0920
- Anticonvulsants -- pharmacology
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Dose-Response Relationship, Drug
- Drug Synergism
- Enzyme Inhibitors -- pharmacology
- Histone Deacetylase Inhibitors
- Humans
- NF-kappa B -- genetics
- Neoplasms -- drug therapy
- Staurosporine -- analogs & derivatives
- Tumor Cells, Cultured
- Valproic Acid -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.